Executive Director, Discovery Biology, Lilly Oncology at Eli Lilly and Company
New York, New York, United States
Join Prog.AI to see contacts
Join Prog.AI to see contacts
Summary
👤
Senior
🎓
Top School
Erin Simonds is an experienced discovery biology leader with 17 years in immunology and a decade driving preclinical programs in oncology, currently directing Discovery Biology for Lilly Oncology in New York. She has deep technical expertise in mouse tumor models, high-parameter single-cell analysis, flow cytometry, cell-based assays, and pharmacokinetic/pharmacodynamic evaluation, and has translated those skills into prioritizing and validating novel oncology targets. Erin grew a seed-stage biotech from 3 to 30 staff through Series A, demonstrating hands-on scaling and cross-functional leadership in addition to robust scientific stewardship. She is a seasoned communicator who regularly presents to boards, advisors, and investors, and has academic roots including a Stanford PhD and Damon Runyon–backed postdoctoral work on combination immunotherapies for glioblastoma. Less obvious: she has contributed to developing new reagents, methods, and bioinformatic tools for mass cytometry that led to patents, blending wet-lab rigor with computational insight.
10 years of coding experience
5 years of employment as a software developer
BS Cellular and Molecular Biology, BS Cellular and Molecular Biology at University of Connecticut
Postdoc (Damon Runyon Fellow) Neurology (William Weiss Lab), Postdoc (Damon Runyon Fellow) Neurology (William Weiss Lab) at University of California, San Francisco
PhD Microbiology & Immunology (Garry Nolan lab), PhD Microbiology & Immunology (Garry Nolan lab) at Stanford University
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Erin Simonds - Executive Director, Discovery Biology, Lilly Oncology at Eli Lilly and Company